Blue Cross Blue Shield notified The University of Texas MD Anderson Cancer Center it will end its Letter of Agreement for Medicare Advantage and Texas Managed Medicaid services, effective Nov. 1, 2024. This does not impact UT System or Texas A&M System retirees on these plans, patients on BCBS commercial or managed care insurance plans, or Medicare patients with a BCBS Medicare Supplemental Plan.
While MD Anderson welcomes...
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed...
As part of its ongoing commitment to patient comfort and healing, The University of Texas MD Anderson Cancer Center today announced a new...
Funda Meric-Bernstam, M.D., chair of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center, has been elected to the National Academy of Medicine (NAM) for her contributions to precision oncology, therapeutics development and biomarker discovery, and for leading practice-changing clinical trials.
The NAM, originally established as the Institute of Medicine in 1970 by the National Academy of Sciences...
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center hosted its second annual scientific...
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small...
The University of Texas MD Anderson Cancer Center today announced an agreement to become a Women’s Cancer Partner with the Union for International...
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...